TriSalus Life Sciences (TLSI) Total Current Liabilities (2022 - 2025)
Historic Total Current Liabilities for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $10.9 million.
- TriSalus Life Sciences' Total Current Liabilities rose 1000.2% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 1000.2%. This contributed to the annual value of $10.2 million for FY2024, which is 3036.02% down from last year.
- Latest data reveals that TriSalus Life Sciences reported Total Current Liabilities of $10.9 million as of Q3 2025, which was up 1000.2% from $9.3 million recorded in Q2 2025.
- Over the past 5 years, TriSalus Life Sciences' Total Current Liabilities peaked at $32.4 million during Q4 2022, and registered a low of $1.7 million during Q2 2022.
- Its 4-year average for Total Current Liabilities is $10.1 million, with a median of $9.9 million in 2024.
- Within the past 5 years, the most significant YoY rise in TriSalus Life Sciences' Total Current Liabilities was 38621.92% (2023), while the steepest drop was 5460.95% (2023).
- Over the past 4 years, TriSalus Life Sciences' Total Current Liabilities (Quarter) stood at $32.4 million in 2022, then tumbled by 54.61% to $14.7 million in 2023, then plummeted by 30.36% to $10.2 million in 2024, then increased by 6.67% to $10.9 million in 2025.
- Its Total Current Liabilities was $10.9 million in Q3 2025, compared to $9.3 million in Q2 2025 and $11.8 million in Q1 2025.